$CNVIF News
Last published 1w ago
- 1w agoCNVIFConavi Medical Presents Data Demonstrating Feasibility of Saline-Based Hybrid IVUS–OCT Imaging with OCTIV™ at TCT 2026GlobeNewswireStudy demonstrates feasibility of saline-based hybrid IVUS-OCT imaging without iodinated contrast during image acquisitionFDA-cleared OCTIV system now in commercial clinical use, with patient cases ongoing TORONTO,
- 1w agoCNVIFConavi Medical Completes First U.S. Commercial Placement and Clinical Cases with its OCTIV™ Hybrid Imaging System to Guide Coronary InterventionsGlobeNewswireDr. Megha Prasad and fellow physicians at NewYork-Presbyterian and Columbia complete first clinical cases with Conavi’s next-generation FDA-cleared hybrid IVUS–OCT imaging systemCompany introduces OCTIV™, powered by
- 3w agoCNVIFConavi Medical Announces New Grants of Stock OptionsGlobeNewswireTORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing and
- 3w agoCNVIFConavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026GlobeNewswireDr. Megha Prasad to deliver podium presentation featuring Conavi’s hybrid IVUS–OCT imagingAbstract presentation on saline-based hybrid IVUS–OCT imagingParticipation in two CRF Imaging Lab physician education sessions
- 1mo agoCNVIFConavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management TeamGlobeNewswireLatest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures Chief Technology Officer Amandeep Thind to lead continued innovation TORONTO, Sept. 17,
- 2mo agoCNVIFConavi Medical Announces Media and Digital Marketing AgreementsGlobeNewswireTORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing,
- 2mo agoCNVIFConavi Medical Reports Fiscal Third Quarter 2026 Results and Operational HighlightsGlobeNewswireNet loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 - $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 - $3.2 million) Ended Fiscal Q3 2026
- 4mo agoCNVIFConavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT ImagingGlobeNewswireTORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing, and
- 4mo agoCNVIFConavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up FundGlobeNewswireTORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. ("Conavi" or the "Company") (TSXV:CNVI, OTCQB:CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and
- 5mo agoCNVIFConavi Medical Reports Fiscal Second Quarter 2026 Results and Operational HighlightsGlobeNewswire- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System- Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging- Advances U.S. Commercial Readiness
- 6mo agoCNVIFConavi Medical Awarded 2026 TAG Innovation AwardGlobeNewswireTORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. ("Conavi" or the "Company") (TSXV:CNVI, OTCQB:CNVIF), a commercial-stage medical device company focused on designing, manufacturing, and marketing
- 7mo agoCNVIFConavi Medical Announces Results from Its Annual General Meeting of ShareholdersGlobeNewswireTORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI, OTCQB:CNVIF) ("Conavi Medical" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and
- 8mo agoCNVIFConavi Medical Reports Fiscal First Quarter 2026 Results and Operational HighlightsGlobeNewswire- Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch- Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO, Feb. 26, 2026
- 10mo agoCNVIFConavi Medical Reports Fiscal Year 2025 Results and Operational HighlightsGlobeNewswireNext-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCIPeer-Reviewed Publications Highlight Clinical
- 1y agoCNVIFConavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up FundGlobeNewswireTORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing, and marketing
- 1y agoCNVIFConavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025GlobeNewswireTORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV:CNVI) (OTCQB:CNVIF), a commercial-stage medical device company focused on intravascular imaging solutions, today announced that it will participate
- 1y agoCNVIFConavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025GlobeNewswireTORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing, and marketing
- 1y agoCNVIFConavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) ClearanceGlobeNewswireUS FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following ClearanceCoronary Intravascular
- 1y agoCNVIFConavi Medical Reports Fiscal Q3 2025 Interim Results and Operational HighlightsGlobeNewswireUS FDA 510(k) submission remains on track for calendar Q3 2025Successful validation testing of Novasight Hybrid™ system with key opinion leaders Recent academic publications underscore importance of intravascular
- 1y agoCNVIFNovasight™ Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary CaseGlobeNewswireTORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV:CNVI) (OTCQB:CNVIF), a leader in hybrid intravascular imaging, is pleased to announce the publication of a compelling case report in the Journal of
- 1y agoCNVIFConavi Medical Applauds New American Journal of Cardiology Study Highlighting Importance of Intracoronary Imaging During PCIGlobeNewswireTORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV:CNVI) (OTCQB:CNVIF), a leader in hybrid intracoronary imaging technologies, is pleased to highlight the recent publication in The American Journal of
- 1y agoCNVIFConavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&AGlobeNewswireTORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi Medical" or the "Company"), is pleased to invite investors and other interested parties to attend the Company's
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum: Now Available for Online ViewingGlobeNewswireNEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and
- 1y agoCNVIFConavi Medical to Present at the Life Sciences Virtual Investor Forum June 12thGlobeNewswireTORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI) (OTCQB:CNVIF) ("Conavi Medical" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing, and
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum Agenda Announced for June 11th-12thGlobeNewswireNEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum June 11th & 12th. This event is
- 1y agoCNVIFConavi Medical Reports Fiscal Q2 2025 Interim Results and Operational HighlightsGlobeNewswireNew U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value propositionUpsized $20 million financing led by U.S.
- 1y agoCNVIFConavi Medical's Novasight Hybrid™ System Named "Product Innovation of the Year" at 2025 Minnesota Manufacturing AwardsGlobeNewswireTORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI, OTCQB:CNVIF) ("Conavi Medical" or the "Company"), a medical device company focused on designing, manufacturing, and marketing imaging
- 1y agoCNVIFConavi Medical Announces Results From Its Annual General Meeting of Shareholders and Adoption of Amendments to Omnibus Equity Incentive PlanGlobeNewswireTORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI, OTCQB:CNVIF) ("Conavi Medical" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and
- 1y agoCNVIFConavi Medical Announces Uplisting to OTCQB Venture MarketGlobeNewswire- Expected to enhance visibility and access to U.S. investors - Trading to commence on March 6, 2025 TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV:CNVI, OTCQB:CNVIF) ("Conavi Medical"
- 1y agoCNVIFConavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational HighlightsGlobeNewswire– Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing – Next-generation Novasight design freeze completed on schedule, usability testing and system validation expected to